Elevated Th17 cells and IL-17/23 levels in skin lesions and serum of vitiligo patients, were positively correlated with disease activity (86, 87), and decreased after narrowband ultraviolet B (NBUVB) treatment (88). This evidence concerns the gene IL17A and vitiligo.